iRhythm Technologies Inc (IRTC):企業の財務・戦略的SWOT分析

◆英語タイトル:iRhythm Technologies Inc (IRTC) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDME16200FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:47
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥27,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥41,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

iRhythm Technologies Inc (IRTC) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

IRhythm Technologies Inc (iRhythm) is a digital health care solutions company. It provides non-invasive long-term cardiac rhythm monitors. The company develops the Zio family of products and solutions to address the clinical needs of patients suffering from arrhythmias. iRhythm’s product offerings include Zio XT and Zio AT Patch a long-term cardiac rhythm monitors. Zio XT service is a long-term, continuous cardiac monitor which detects arrhythmias including atrial fibrillation (AFib). The company offers ZIO Service in the US to physicians, hospitals and clinics through a direct sales organization. iRhythm is headquartered in San Francisco, California, the US.

iRhythm Technologies Inc Key Recent Developments

Apr 10,2021: iRhythm Technologies Announces Conference Call to Discuss Medicare Administrative Contractor (MAC) Novitas’s Updated Rate Publication
Feb 25,2021: iRhythm Technologies announces fourth quarter and full year 2020 financial results
Feb 11,2021: iRhythm Technologies to Report Fourth Quarter and Full Year 2020 Financial Results on February 25, 2021
Jan 29,2021: iRhythm Technologies provides statement on Medicare Administrative Contractor MAC Novitas recent rate publication
Dec 14,2020: iRhythm Technologies president and CEO Kevin King to retire; Michael Coyle joins company as president and CEO effective January 12, 2021

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
iRhythm Technologies Inc – Key Facts
iRhythm Technologies Inc – Key Employees
iRhythm Technologies Inc – Key Employee Biographies
iRhythm Technologies Inc – Major Products and Services
iRhythm Technologies Inc – History
iRhythm Technologies Inc – Company Statement
iRhythm Technologies Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
iRhythm Technologies Inc – Business Description
iRhythm Technologies Inc – Corporate Strategy
iRhythm Technologies Inc – SWOT Analysis
SWOT Analysis – Overview
iRhythm Technologies Inc – Strengths
iRhythm Technologies Inc – Weaknesses
iRhythm Technologies Inc – Opportunities
iRhythm Technologies Inc – Threats
iRhythm Technologies Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
iRhythm Technologies Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
iRhythm Technologies Inc, Medical Equipment, Deals By Type, 2015 to YTD 2021
iRhythm Technologies Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Apr 10, 2021: iRhythm Technologies Announces Conference Call to Discuss Medicare Administrative Contractor (MAC) Novitas’s Updated Rate Publication
Feb 25, 2021: iRhythm Technologies announces fourth quarter and full year 2020 financial results
Feb 11, 2021: iRhythm Technologies to Report Fourth Quarter and Full Year 2020 Financial Results on February 25, 2021
Jan 29, 2021: iRhythm Technologies provides statement on Medicare Administrative Contractor MAC Novitas recent rate publication
Dec 14, 2020: iRhythm Technologies president and CEO Kevin King to retire; Michael Coyle joins company as president and CEO effective January 12, 2021
Dec 02, 2020: iRhythm Technologies comments on Centers for Medicare and Medicaid Services 2021 medicare physician fee schedule final rule
Nov 05, 2020: iRhythm Technologies announces third quarter 2020 financial results
Nov 05, 2020: iRhythm announces third quarter 2020 financial results
Oct 22, 2020: iRhythm Tech to Report Third Quarter 2020 Financial Results on November 5, 2020
Aug 06, 2020: iRhythm Technologies announces second quarter 2020 financial results
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
iRhythm Technologies Inc, Key Facts
iRhythm Technologies Inc, Key Employees
iRhythm Technologies Inc, Key Employee Biographies
iRhythm Technologies Inc, Major Products and Services
iRhythm Technologies Inc, History
iRhythm Technologies Inc, Other Locations
iRhythm Technologies Inc, Subsidiaries
iRhythm Technologies Inc, Key Competitors
iRhythm Technologies Inc, Ratios based on current share price
iRhythm Technologies Inc, Annual Ratios
iRhythm Technologies Inc, Annual Ratios (Cont...1)
iRhythm Technologies Inc, Interim Ratios
iRhythm Technologies Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
iRhythm Technologies Inc, Medical Equipment, Deals By Type, 2015 to YTD 2021
iRhythm Technologies Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[iRhythm Technologies Inc (IRTC):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • KARL STORZ GmbH & Co KG-医療機器分野:企業M&A・提携分析
    Summary KARL STORZ GmbH & Co KG (Karl Storz) is a manufacturer and distributor of endoscopes, surgical devices and medical instruments. The company offers rigid and flexible endoscopes, instruments for the field of human medicine used for neurosurgery; oral and maxillofacial surgery; ear, nose, and …
  • MediWound Ltd (MDWD):企業の財務・戦略的SWOT分析
    MediWound Ltd (MDWD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • 3i Infotech Ltd (3IINFOTECH):企業の財務・戦略的SWOT分析
    3i Infotech Ltd (3IINFOTECH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Abion Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Abion Inc (Abion) is a biopharmaceutical company that conducts research activities to develop biopharmaceutical drugs and companion diagnostic systems for the treatment of incurable diseases. The company offers preclinical phase products such as ABN101, ABN301, ABN302, ABN401, and others. It …
  • Compagnie Financiere Richemont SA:戦略・SWOT・企業財務分析
    Compagnie Financiere Richemont SA - Strategy, SWOT and Corporate Finance Report Summary Compagnie Financiere Richemont SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Stora Enso Oyj:企業の戦略・SWOT・財務分析
    Stora Enso Oyj - Strategy, SWOT and Corporate Finance Report Summary Stora Enso Oyj - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • The British Land Company PLC:企業の戦略・SWOT・財務分析
    The British Land Company PLC - Strategy, SWOT and Corporate Finance Report Summary The British Land Company PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Svevind AB-エネルギー分野:企業M&A・提携分析
    Summary Svevind AB (Svevind) is a renewable energy company that plans, develops and operates land-based wind power projects of different sizes. The company’s services portfolio includes wind project planning, design, sale and electricity generation. Its projects include Gabrielsberget, Hornefors, Gr …
  • Akashi Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Akashi Therapeutics Inc (Akashi Therapeutics), formerly DART Therapeutics Inc is a clinical stage biopharmaceutical company develops treatment for duchenne muscular dystrophy (DMD) and other rare pediatric diseases. The company provides pipeline portfolio such as HT-100, a small molecule dru …
  • Paramount Resources Ltd (POU):企業の財務・戦略的SWOT分析
    Summary Paramount Resources Ltd (Paramount Resources) is an energy company that offers exploration, production, development, and marketing of oil and gas products. The company offers products such s crude oil, fuel oil, natural gas and natural gas liquids. It operates in three segments such as princ …
  • Eurofarma Laboratorios SA-製薬・医療分野:企業M&A・提携分析
    Summary Eurofarma Laboratorios SA (Eurofarma), formerly Bill Farmaceutica is a pharmaceutical company that manufactures and markets prescription, generic and veterinary drugs. The company offers prescription products which include aerosol ointment, alprazolam, acebrophylline, altiva, ebastel, fluoru …
  • Black Stone Minerals LP (BSM):石油・ガス:M&Aディール及び事業提携情報
    Summary Black Stone Minerals LP (Black Stone) is a mining and minerals exploration and development company that explores and produces mineral deposits. The company's services include participating on a working interest basis when economics are favorable, leasing minerals to exploration and productio …
  • El Paso Electric Company:発電所・企業SWOT分析
    El Paso Electric Company - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key empl …
  • GenSight Biologics SA (SIGHT):製薬・医療:M&Aディール及び事業提携情報
    Summary GenSight Biologics SA (GenSight) is a clinical stage biotechnology company that discovers and develops novel therapies for mitochondrial and neurodegenerative diseases. The company’s product pipeline comprises GS010 and GS030 developed for the treatment of retinal degenerative diseases. It d …
  • GTx Inc (GTXI):製薬・医療:M&Aディール及び事業提携情報
    Summary GTx Inc (GTx) is a biopharmaceutical company that discovers, develops and commercializes novel targeted hormonal therapies. It develops small molecules that targets hormone pathways for the treatment of various cancers including breast and prostate cancer; and other serious medical condition …
  • Resverlogix Corp (RVX)-製薬・医療分野:企業M&A・提携分析
    Summary Resverlogix Corp (Resverlogix) is an epigenetics company that develops small molecule therapeutics for Bromodomain and ExtraTerminal Domain (BET) inhibition. The company provides lead product such as RVX-208 (apabetalone), is a BET inhibitor under phase III clinical trial. Its RVX-208 is bei …
  • QinetiQ Group Plc:企業の戦略・SWOT・財務情報
    QinetiQ Group Plc - Strategy, SWOT and Corporate Finance Report Summary QinetiQ Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Key Petroleum Ltd (KEY):企業の財務・戦略的SWOT分析
    Summary Key Petroleum Ltd (Key Petroleum) is an oil and gas exploration and production company that acquires, explores and develops oil and gas properties. The company carries out projects such as Canning Basin and Perth Basin. It holds interest in exploration permits such as EP 438, EP 448, EP 104/ …
  • Implenia AG:戦略・SWOT・企業財務分析
    Implenia AG - Strategy, SWOT and Corporate Finance Report Summary Implenia AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Oasis Petroleum Inc (OASPQ):企業の財務・戦略的SWOT分析
    Oasis Petroleum Inc (OASPQ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆